News
The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...
Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...
Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...
A global trial finds Wegovy and Ozempic significantly improve liver health in patients and treats those with advanced fatty ...
23h
Parade on MSNWegovy May Help With a Serious Condition You Didn't Know You HadChances are, you haven’t heard of metabolic dysfunction–associated steatohepatitis (MASH)—but you’ve almost definitely heard ...
commonly known by brand names Ozempic and Wegovy, has the ability to counter metabolic dysfunction-associated steatohepatitis, or MASH, liver disease and some of its risk factors. MASH is ...
Scientists are continuing to find evidence that GLP-1 medications can temper cravings for alcohol and other drugs.
Drugs made to treat diabetes and weight loss could stop or even reverse a severe liver disease, according to a new study. Researchers administered weekly injections — either a placebo or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results